AEHR TEST SYSTEMS DL-,01

Vernon Rogers, Executive VP of Sales & Marketing at Aehr Test Systems, sold 5,994 shares for $141.34 each, totaling about $847,192, and now holds 186,232 shares valued at roughly $27.1 million. The sale trimmed his direct stake by about 3% and follows a strong stock rally (about 695% over the prior 12 months) amid rising demand for the company’s semiconductor test equipment. Aehr reported improving quarterly revenue and bookings but remains pre-profitable on a trailing twelve-month basis with net losses of $7.1 million against $50 million in revenue. » More on finance.yahoo.com

Gayn Erickson sold 40,000 indirectly held shares on August 12 for a weighted average price of $130.84, generating about $5.2 million and reducing that trust interest by roughly 20%. After the sale he retains about 355,000 beneficial shares including unvested RSUs and restricted shares, limiting immediate further disposals. The transaction occurred amid a 564% year‑over‑year stock surge and while the company reports trailing‑12‑month revenue of $50.9 million and a net loss of $7.1 million. » More on finance.yahoo.com

Shares of Aehr Test Systems climbed in premarket trading after a follow-up order of $22 million for wafer-level burn-in systems from a leading AI processor customer was announced and the expectation that the equipment will be delivered to Taiwan within six months. Jefferies initiated coverage with a buy rating and a $175 price target, citing Aehr’s unique position in wafer- and package-level burn-in, a projected CAGR of 52% through FY2028, and rising gross margins. Momentum is supported by strong quarterly results with increases in revenue and earnings and a record high order intake; insider sales following option exercises were described as routine. » More on de.investing.com

Aehr Test Systems reported a follow-on order worth $22 million from its leading AI-processor customer for FOX‑XP systems and FOX WaferPak components. The stock rose about 10.7% intraday to a 52-week high of $133.35. In fiscal Q4 2026 the company returned to profitability with earnings of $0.11 per share, revenue increased 33% to around $18.8 million, and order intake hit a record $60.7 million with a backlog of about $100.6 million. Management’s revenue guidance for FY2027 of $130–150 million raised market expectations; a reported insider sale did not materially dampen the positive market reaction. » More on de.investing.com

Aehr Test Systems reported blowout fiscal Q4 results with $18.84M revenue, net income of $1.39M and record bookings of $60.7M, lifting backlog to $100.6M. Management guided fiscal 2027 revenue to $130M–$150M, implying up to 200% year-over-year growth driven by AI processor burn‑in and silicon photonics testing. The stock has surged year-to-date but trades at a rich 69x price-to-sales, while recent insider selling and a shelf filing introduce capital-raising and dilution risk. Wall Street coverage is generally constructive, but further upside depends on execution and estimates catching up to the guidance. » More on finance.yahoo.com